{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:02:38Z","timestamp":1794603758929,"version":"4.9.1"},"reference-count":69,"publisher":"American Association for Cancer Research (AACR)","issue":"9","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Genetically engineered mouse models (GEMM) have fundamentally changed how ovarian cancer etiology, early detection, and treatment are understood. MYC, an oncogene, is amongst the most amplified genes in high-grade serous ovarian cancer (HGSOC), but it has not previously been utilized to drive HGSOC GEMMs. We coupled Myc and dominant-negative mutant p53-R270H with a fallopian tube epithelium (FTE)-specific promoter Ovgp1 to generate a new GEMM of HGSOC. Female mice developed lethal cancer at an average of 14.5 months. Histopathologic examination of mice revealed HGSOC characteristics, including nuclear p53 and nuclear MYC in clusters of cells within the FTE and ovarian surface epithelium. Unexpectedly, nuclear p53 and MYC clustered cell expression was also identified in the uterine luminal epithelium, possibly from intraepithelial metastasis from the FTE. Extracted tumor cells exhibited strong loss of heterozygosity at the p53 locus, leaving the mutant allele. Copy-number alterations in these cancer cells were prevalent, disrupting a large fraction of genes. Transcriptome profiles most closely matched human HGSOC and serous endometrial cancer. Taken together, these results demonstrate that the Myc and Trp53-R270H transgenes were able to recapitulate many phenotypic hallmarks of HGSOC through the utilization of strictly human-mimetic genetic hallmarks of HGSOC. This new mouse model enables further exploration of ovarian cancer pathogenesis, particularly in the 50% of HGSOC which lack homology-directed repair mutations. Histologic and transcriptomic findings are consistent with the hypothesis that uterine serous cancer may originate from the FTE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Mouse models using transgenes which generate spontaneous cancers are essential tools to examine the etiology of human diseases. Here, the first Myc-driven spontaneous model is described as a valid HGSOC model. Surprisingly, aspects of uterine serous carcinoma were also observed in this model.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0144","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T09:27:06Z","timestamp":1725355626000},"page":"2525-2538","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-124X","authenticated-orcid":false,"given":"Alexandra","family":"Blackman","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7899-9528","authenticated-orcid":false,"given":"Amy C.","family":"Rees","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-2114","authenticated-orcid":false,"given":"Robert R.","family":"Bowers","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-2967","authenticated-orcid":false,"given":"Christian M.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5811-1659","authenticated-orcid":false,"given":"Silvia G.","family":"Vaena","sequence":"additional","affiliation":[{"name":"Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0319-1656","authenticated-orcid":false,"given":"Madison A.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3826-005X","authenticated-orcid":false,"given":"Shelby","family":"Carter","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6095-3748","authenticated-orcid":false,"given":"Evan D.","family":"Villamor","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8311-8933","authenticated-orcid":false,"given":"Della","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2139-6422","authenticated-orcid":false,"given":"Anthony J.","family":"Emanuel","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-0559","authenticated-orcid":false,"given":"George","family":"Fullbright","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2075-8519","authenticated-orcid":false,"given":"Matthew S.","family":"O\u2019Malley","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Indiana University Bloomington, Bloomington, Indiana. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9986-6493","authenticated-orcid":false,"given":"Richard L.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Indiana University Bloomington, Bloomington, Indiana. 5"},{"name":"Department of Biochemistry and Molecular Biology, Indiana University Bloomington, Bloomington, Indiana. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-0316","authenticated-orcid":false,"given":"David T.","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1895-5203","authenticated-orcid":false,"given":"Laura S.","family":"Spruill","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-1862","authenticated-orcid":false,"given":"Martin J.","family":"Romeo","sequence":"additional","affiliation":[{"name":"Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0158-1575","authenticated-orcid":false,"given":"Brian C.","family":"Orr","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9746-0764","authenticated-orcid":false,"given":"Kristi L.","family":"Helke","sequence":"additional","affiliation":[{"name":"Department of Comparative Medicine, Medical University of South Carolina, Charleston, South Carolina. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8978-5961","authenticated-orcid":false,"given":"Joe R.","family":"Delaney","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"2025040317221541300_bib1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/ijgc-2021-002753","article-title":"Uterine serous carcinoma: key advances and novel treatment approaches","volume":"31","author":"Ferriss","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"2025040317221541300_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2022.0009","article-title":"Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype","volume":"8","author":"Clarke","year":"2022","journal-title":"JAMA Oncol"},{"key":"2025040317221541300_bib3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Gonz\u00e1lez-Mart\u00edn","year":"2019","journal-title":"N Engl J Med"},{"key":"2025040317221541300_bib4","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N Engl J Med"},{"key":"2025040317221541300_bib5","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N Engl J Med"},{"key":"2025040317221541300_bib6","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N Engl J Med"},{"key":"2025040317221541300_bib7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"key":"2025040317221541300_bib8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.5858\/arpa.2017-0231-RA","article-title":"Serous tubal intraepithelial carcinoma or not? Metastases to fallopian tube mucosa can masquerade as in situ lesions","volume":"141","author":"Singh","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"2025040317221541300_bib9","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"2025040317221541300_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/cancers10110433","article-title":"Cell origins of high-grade serous ovarian cancer","volume":"10","author":"Kim","year":"2018","journal-title":"Cancers (Basel)"},{"key":"2025040317221541300_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.4783","article-title":"Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse","volume":"240","author":"Wu","year":"2016","journal-title":"J Pathol"},{"key":"2025040317221541300_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4927","article-title":"High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease","volume":"243","author":"Zhai","year":"2017","journal-title":"J Pathol"},{"key":"2025040317221541300_bib13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4161\/cbt.6.11.4830","article-title":"Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer","volume":"6","author":"Hensley","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"2025040317221541300_bib14","doi-asserted-by":"crossref","first-page":"e1008558","DOI":"10.1371\/journal.pgen.1008558","article-title":"Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors","volume":"16","author":"Delaney","year":"2020","journal-title":"PLoS Genet"},{"key":"2025040317221541300_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/scbi.2000.0342","article-title":"Cellular transformation by SV40 large T antigen: interaction with host proteins","volume":"11","author":"Ali","year":"2001","journal-title":"Semin Cancer Biol"},{"key":"2025040317221541300_bib16","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.1038\/sj.onc.1209046","article-title":"SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation","volume":"24","author":"Ahuja","year":"2005","journal-title":"Oncogene"},{"key":"2025040317221541300_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"2025040317221541300_bib18","doi-asserted-by":"crossref","first-page":"D316","DOI":"10.1093\/nar\/gkab996","article-title":"ReMap 2022: a database of human, mouse, drosophila and arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments","volume":"50","author":"Hammal","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2025040317221541300_bib19","first-page":"116","article-title":"Bacterial artificial chromosome libraries for mouse sequencing and functional analysis","volume":"10","author":"Osoegawa","year":"2000","journal-title":"Genome Res"},{"key":"2025040317221541300_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","article-title":"Tumor spectrum analysis in p53-mutant mice","volume":"4","author":"Jacks","year":"1994","journal-title":"Curr Biol"},{"key":"2025040317221541300_bib21","doi-asserted-by":"crossref","first-page":"W395","DOI":"10.1093\/nar\/gkaa434","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update","volume":"48","author":"Jalili","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2025040317221541300_bib22","doi-asserted-by":"crossref","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2025040317221541300_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2025040317221541300_bib24","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2025040317221541300_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"2025040317221541300_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat Biotechnol"},{"key":"2025040317221541300_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12967-021-02936-w","article-title":"TPM, FPKM, or normalized counts? A comparative study of quantification measures for the analysis of RNA-seq data from the NCI patient-derived models repository","volume":"19","author":"Zhao","year":"2021","journal-title":"J Transl Med"},{"key":"2025040317221541300_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"2025040317221541300_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00335-015-9573-z","article-title":"MouseMine: a new data warehouse for MGI","volume":"26","author":"Motenko","year":"2015","journal-title":"Mamm Genome"},{"key":"2025040317221541300_bib30","doi-asserted-by":"crossref","first-page":"baac054","DOI":"10.1093\/database\/baac054","article-title":"HumanMine: advanced data searching, analysis and cross-species comparison","volume":"2022","author":"Lyne","year":"2022","journal-title":"Database (Oxford)"},{"key":"2025040317221541300_bib31","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2025040317221541300_bib32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"2025040317221541300_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PGP.0000000000000207","article-title":"Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: a rereview of cases lacking TP53 mutations in the cancer genome atlas ovarian study","volume":"35","author":"Vang","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"2025040317221541300_bib34","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2025040317221541300_bib35","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1016\/j.cell.2023.07.004","article-title":"Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer","volume":"186","author":"Chowdhury","year":"2023","journal-title":"Cell"},{"key":"2025040317221541300_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2018.06.018","article-title":"Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics","volume":"80","author":"Prat","year":"2018","journal-title":"Hum Pathol"},{"key":"2025040317221541300_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcdb.2014.03.019","article-title":"Genetically engineered mouse models for epithelial ovarian cancer: are we there yet?","volume":"27","author":"Howell","year":"2014","journal-title":"Semin Cell Dev Biol"},{"key":"2025040317221541300_bib38","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.3390\/ijms21134806","article-title":"Modelling epithelial ovarian cancer in mice: classical and emerging approaches","volume":"21","author":"Zakarya","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025040317221541300_bib39","doi-asserted-by":"crossref","first-page":"601512","DOI":"10.3389\/fonc.2021.601512","article-title":"c-MYC and epithelial ovarian cancer","volume":"11","author":"Reyes-Gonz\u00e1lez","year":"2021","journal-title":"Front Oncol"},{"key":"2025040317221541300_bib40","doi-asserted-by":"crossref","first-page":"e39030","DOI":"10.7554\/eLife.39030","article-title":"Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12\/13","volume":"7","author":"Zeng","year":"2018","journal-title":"Elife"},{"key":"2025040317221541300_bib41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1158\/0008-5472.CAN-19-1036","article-title":"Gain-of-function mutant p53 R273H interacts with replicating DNA and PARP1 in breast cancer","volume":"80","author":"Xiao","year":"2020","journal-title":"Cancer Res"},{"key":"2025040317221541300_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jmcb\/mjaa040","article-title":"Gain-of-function mutant p53 in cancer progression and therapy","volume":"12","author":"Zhang","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"2025040317221541300_bib43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/acel.12194","article-title":"Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction","volume":"13","author":"Miller","year":"2014","journal-title":"Aging Cell"},{"key":"2025040317221541300_bib44","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1210\/en.2012-1340","article-title":"Minireview: translational animal models of human menopause: challenges and emerging opportunities","volume":"153","author":"Diaz Brinton","year":"2012","journal-title":"Endocrinology"},{"key":"2025040317221541300_bib45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2025040317221541300_bib46","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"2025040317221541300_bib47","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3892\/ol.2013.1121","article-title":"PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas","volume":"5","author":"Xiang","year":"2013","journal-title":"Oncol Lett"},{"key":"2025040317221541300_bib48","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"2025040317221541300_bib49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/diagnostics10020102","article-title":"Serous tubal intraepithelial carcinoma: a concise review for the practicing pathologist and clinician","volume":"10","author":"Bachert","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2025040317221541300_bib50","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat Commun"},{"key":"2025040317221541300_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0165-4608(02)00673-8","article-title":"Establishment of a new human cell line (EN) with TP53 mutation derived from endometrial carcinoma","volume":"141","author":"Isaka","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"2025040317221541300_bib52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2025040317221541300_bib53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2025040317221541300_bib54","first-page":"1389","article-title":"Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer","volume":"63","author":"Connolly","year":"2003","journal-title":"Cancer Res"},{"key":"2025040317221541300_bib55","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","article-title":"A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development","volume":"233","author":"Sherman-Baust","year":"2014","journal-title":"J Pathol"},{"key":"2025040317221541300_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"2025040317221541300_bib57","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/nar\/gkac200","article-title":"SWAN pathway-network identification of common aneuploidy-based oncogenic drivers","volume":"50","author":"Bowers","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2025040317221541300_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"2025040317221541300_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ctrv.2018.06.004","article-title":"Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction","volume":"69","author":"Gockley","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"2025040317221541300_bib60","doi-asserted-by":"crossref","first-page":"e8534","DOI":"10.1371\/journal.pone.0008534","article-title":"Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas","volume":"4","author":"Clark-Knowles","year":"2009","journal-title":"PLoS One"},{"key":"2025040317221541300_bib61","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","article-title":"Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice","volume":"68","author":"Daikoku","year":"2008","journal-title":"Cancer Res"},{"key":"2025040317221541300_bib62","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/onc.2012.232","article-title":"Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis","volume":"32","author":"Akbay","year":"2013","journal-title":"Oncogene"},{"key":"2025040317221541300_bib63","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"key":"2025040317221541300_bib64","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1186\/s12885-019-6174-3","article-title":"Tubal ligation and endometrial Cancer risk: a global systematic review and meta-analysis","volume":"19","author":"Loghmani","year":"2019","journal-title":"BMC Cancer"},{"key":"2025040317221541300_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ijc.31287","article-title":"Association between tubal ligation and endometrial cancer risk: a Swedish population-based cohort study","volume":"143","author":"Falconer","year":"2018","journal-title":"Int J Cancer"},{"key":"2025040317221541300_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"2025040317221541300_bib67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2020.04.707","article-title":"Fallopian tube abnormalities in uterine serous carcinoma","volume":"158","author":"Steenbeek","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2025040317221541300_bib68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/modpathol.2014.76","article-title":"Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma","volume":"28","author":"Jia","year":"2015","journal-title":"Mod Pathol"},{"key":"2025040317221541300_bib69","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","article-title":"Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance","volume":"28","author":"Jarboe","year":"2009","journal-title":"Int J Gynecol Pathol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0144\/3491932\/crc-24-0144.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/9\/2525\/3500866\/crc-24-0144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/9\/2525\/3500866\/crc-24-0144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:52:39Z","timestamp":1743727959000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/9\/2525\/748642\/MYC-is-Sufficient-to-Generate-Mid-Life-High-Grade"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0144","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.27109528.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109540.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109525.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109543.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109522.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109537","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109516.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109549","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109513","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109525","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109519","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109552.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109519.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109513.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728248","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109555","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728236","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109531","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109543","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109510.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109555.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728242","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728230","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109549.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109516","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109528","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728233","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109540","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109552","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728245","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109522","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109531.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109534","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728239","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109534.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28728227","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109510","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109537.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7467604.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2024.01.24.576924","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7467604","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}